Skip to main content
. Author manuscript; available in PMC: 2012 Mar 15.
Published in final edited form as: Neuroimage. 2010 Dec 31;55(2):522–531. doi: 10.1016/j.neuroimage.2010.12.073

Table 1.

Demographics

Reference CN n = 21 Path confirmed FTD n = 47
CN scans n = 120 AD n = 48 DLB n = 20
No. with scan primary diagnosis matches pathology (%) 120 (100) 19 (90) 43 (90) 14 (70) 38 (81)
No. of females (%) 63 (53) 14 (67) 27 (56) 7 (35) 23 (49)
Median age at scan, yr (min, max) 76 (55, 90) 84 (53, 99) 76 (46, 96) 74 (59, 89) 59 (34, 84)
Median age at death, yr (min, max)* 89 (75, 99) 89 (57, 103) 81 (51, 103) 78 (62, 93) 67 (35, 90)
Median time from scan to death, yr (min, max) 7.6 (3.1, 11.4) 4.0 (1.2, 10.5) 5.4 (2.3, 12.4) 4.4 (0.2, 8.0) 3.7 (0.2, 9.0)
Median education, yr (min, max) 14 (8, 20) 15 (8, 20) 14 (8, 18) 15 (8, 20) 14 (8, 20)
No. of APOE e4 carriers (%) 32 (27) 5 (24) 25 (54) 8 (42) 8 (27)
Median MMSE (min, max) 29 (24, 30) 29 (25, 30) 23 (11, 29) 24 (15, 28) 24 (2, 30)
Median CDR sum of boxes (min, max) 0.0 (0.0, 0.5) 0.0 (0.0, 2.0) 4.0 (0.5, 17.0) 4.3 (1.5, 11.0) 5.5 (0.5, 18.0)
*

There were 33 patients from the control reference scan group that died.

There were 20 patients missing APOE genotyping.